Title	Date	Price
U.S. OTC Diagnostics Products Market Sales, 1992-2007 This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific...	Jan, 2006	€80
U.S. Over the Counter Pregnancy Testing Market Dollar Volume, 1996-2014 This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific...	Jan, 2006	€80
Worldwide OTC Diagnostics Products Market, 2001-2007 This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific...	Jan, 2006	€80
The Pregnancy Test Market for OTC Testing in the U.S., 1996-2007 This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific...	Jan, 2006	€80
Stakeholder Opinions: Small Cell Lung Cancer and Malignant Mesothelioma - Limited R&D activity provides opportunity for early-phase pipeline drugs Introduction SCLC accounts for one-fifth of all lung tumor types. More than 80,000 new cases are expected to be diagnosed in 2007 in the seven major markets, although it is set to decrease due to changing...	Mar, 2007	€3 040
OTC Healthcare in India to 2010 Introduction This databook is a detailed information resource covering all the key data points on OTC Healthcare in India. It includes comprehensive value volume segmentation and market share data. The...	Feb, 2007	€396
U.K. OTC Diagnostics Products Market Sales, 1998-2007 This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific...	Jan, 2006	€80
New Drugs in Development for Asthma This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific...	Jan, 2006	€80
Total Prescriptions and Refills of Major Antihistamine Drugs, 2002 This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific...	Jan, 2006	€80
U.S. Asthma Episodes per 1,000 People, 1999-2003 This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific...	Jan, 2006	€80
AstraZeneca: PharmaVitae Profile 2005 Introduction This analysis examines the current position and future outlook for AstraZeneca in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline...	Dec, 2005	€4 845
Stakeholder Perspectives: Influenza Vaccines - Flying back Into Flu Introduction Influenza is a highly infectious disease which globally infects 10-20% of the population every year causing up to 500,000 deaths. Although all persons are at risk, the elderly and the young...	Dec, 2005	€6 460
Commercial Insight: Antidyslipidemics - Statins Hit the Brakes on Market Growth Introduction The antidyslipidemics market is driven by the statins, which account for 87% of it. However, as many statins are expected to face patent expiry in the coming decade their role is expected...	Dec, 2005	€10 000
Stakeholder Opinions: Renal Cell Carcinoma - Novel Targeted Treatments to Fill the Void Introduction A meager 20% of metastatic RCC tumors respond to standard cytokine therapy, thus rendering 80% of advanced RCC patients without any effective treatment. Further, with up to 50% of stage one...	Dec, 2005	€3 230
Commercial Insight: Disease Modification in Rheumatoid Arthritis - The Biologics Boom Introduction The global Rheumatoid Arthritis (RA) market has experienced extraordinary growth over the last decade. This market valued at $4.14 billion in 2004, shows no hint of decline. The explosion...	Dec, 2005	€10 000
Pipeline and Commercial Perspectives: Insomnia Introduction Until recently, the insomnia market has been dominated by Ambien, Sonata, and Imovane, and the older hypnotics such as benzodiazepines. However, the global insomnia market is set to grow from...	Dec, 2005	€10 000
OTC Healthcare in Indonesia to 2010 Introduction This databook is a detailed information resource covering all the key data points on OTC Healthcare in Indonesia. It includes comprehensive value volume segmentation and market share data....	Feb, 2007	€396
Commercial Insight: Antihypertensives - Two Years to Shape the Market? Introduction Datamonitor expects the antihypertensive market to exceed $50bn by 2014 across the seven major markets, with novel treatments and the market-leading ARBs delivering much of this value. However,...	Dec, 2005	€10 000
Stakeholder Insight: Hepatitis in China - Liver Let Die? Introduction Hepatitis is a major health problem in China, which is home to one third of hepatitis B patients and one quarter of hepatitis C patients globally. HBV vaccination, together with HBV and HCV...	Dec, 2005	€10 000
Commercial Insight: Generic Cancer Market - New Legislation and a Wave of Patent Expiries to Transform the Market Introduction Over the next 10 years a significant number of key oncology products, some with blockbuster status, will lose patent protection, thus exposing billions of dollars to generic erosion. While...	Dec, 2005	€10 000